The search for new anticoagulants: dabigatran etexilate

Author： Siddique Aurangzeb   Shantsila Eduard   Lip Gregory YH  

Publisher： Future Medicine

ISSN： 1475-0708

Source： Therapy, Vol.5, Iss.6, 2008-11, pp. : 793-796

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Dabigatran etexilate: An alternative to warfarin for patients with nonvalvular atrial fibrillation

By  

JOURNAL OF THE AMERICAN ASSOCIATION OF NURSE PRACTITIONERS (ELECTRONIC), Vol. 27, Iss. 4, 2015-04 ,pp. : 190-196

John Wiley & Sons Inc

Access to resources Recommend Favorite

Plasma lipids affect dabigatran etexilate anticoagulation in rats with unbalanced diabetes mellitus

By  

JOURNAL OF DIABETES, Vol. 10, Iss. 3, 2018-03 ,pp. : 240-248

John Wiley & Sons Inc

Access to resources Recommend Favorite

New Oral Anticoagulants and Their Reversal

By  

Current Drug Safety, Vol. 10, Iss. 3, 2015-01 ,pp. : 208-216

Bentham Science Publishers

Access to resources Recommend Favorite

Physiologically based pharmacokinetic modelling and in vivo [I]/Ki accurately predict P‐glycoprotein‐mediated drug‐drug interactions with dabigatran etexilate

By  

BRITISH JOURNAL OF PHARMACOLOGY (ELECTRONIC), Vol. 171, Iss. 4, 2014-02 ,pp. : 1043-1053

John Wiley & Sons Inc

Access to resources Recommend Favorite

Design of Randomized, double‐blind, Evaluation in secondary Stroke Prevention comparing the EfficaCy and safety of the oral Thrombin inhibitor dabigatran etexilate vs. acetylsalicylic acid in patients with Embolic Stroke of Undetermined Source (RE‐SPECT ESUS)

By  

INTERNATIONAL JOURNAL OF STROKE, Vol. 10, Iss. 8, 2015-12 ,pp. : 1309-1312

John Wiley & Sons Inc

Access to resources Recommend Favorite